The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
- Conditions
- HIV Infections
- Registration Number
- NCT00007436
- Lead Sponsor
- Gilead Sciences
- Brief Summary
The purpose of this study is to evaluate the safety of tenofovir disoproxil fumarate (tenofovir DF) in combination with other anti-HIV drugs in patients who have participated in other tenofovir DF studies (GS-98-902 or GS-99-907), are able to tolerate the drug at different doses, and may benefit from having tenofovir DF treatment.
- Detailed Description
Patients take tenofovir DF in combination with other antiretrovirals.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (19)
East Bay AIDS Ctr
🇺🇸Berkeley, California, United States
Tower ID Med Associates
🇺🇸Los Angeles, California, United States
Pacific Horizons Med Group
🇺🇸San Francisco, California, United States
Harbor - UCLA Med Ctr
🇺🇸Torrance, California, United States
Univ of Colorado / Health Science Ctr
🇺🇸Denver, Colorado, United States
Physicans Home Service
🇺🇸Washington, District of Columbia, United States
Steinhart Medical Associates
🇺🇸Miami, Florida, United States
Dr Gerald Pierone Jr
🇺🇸Vero Beach, Florida, United States
Northstar Med Clinic
🇺🇸Chicago, Illinois, United States
CRI New England
🇺🇸Brookline, Massachusetts, United States
Scroll for more (9 remaining)East Bay AIDS Ctr🇺🇸Berkeley, California, United States